Supplementary figure 3. Concentration-effect curve for dupilumab level at 12 weeks and ΔEASI at 48 weeks.

Published: 11 April 2023| Version 1 | DOI: 10.17632/5zm833zvw7.1
Contributor:

Description

Concentration-effect curve showing the dupilumab serum level in μg/mL at 12 weeks on the x-axis and correlating ΔEASI at 48 weeks (versus baseline) on the y-axis. All patients were sorted from low to high drug concentration, with each dot representing the mean concentration with SDs and correlating ΔEASI for 10 patients (last group 12 patients).

Files

Institutions

Universiteit van Amsterdam

Categories

Atopic Dermatitis, Drug Concentration

Licence